- $2.07bn
- $1.54bn
- $874.18m
- 94
- 40
- 98
- 92
Annual income statement for Argan, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 392 | 509 | 455 | 573 | 874 |
Cost of Revenue | |||||
Gross Profit | 62.1 | 99.7 | 86.4 | 80.8 | 141 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 369 | 465 | 413 | 537 | 786 |
Operating Profit | 23 | 44.5 | 41.7 | 36.5 | 88.2 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 24.9 | 47.1 | 46 | 48.9 | 111 |
Provision for Income Taxes | |||||
Net Income After Taxes | 19.4 | 35.7 | 34.7 | 32.4 | 85.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 23.9 | 38.2 | 33.1 | 32.4 | 85.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 23.9 | 38.2 | 33.1 | 32.4 | 85.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.23 | 2.78 | 2.33 | 2.39 | 6.15 |
Dividends per Share | |||||
Special Dividends per Share |